These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16207615)

  • 1. In vitro and in vivo evaluation of two extended release preparations of combination metformin and glipizide.
    Defang O; Shufang N; Wei L; Hong G; Hui L; Weisan P
    Drug Dev Ind Pharm; 2005 Aug; 31(7):677-85. PubMed ID: 16207615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and evaluation of compound metformin/glipizide elementary osmotic pump tablets.
    Ouyang D; Nie S; Li W; Guo H; Liu H; Pan W
    J Pharm Pharmacol; 2005 Jul; 57(7):817-20. PubMed ID: 15969939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronized and controlled release of metformin hydrochloride/glipizide from elementary osmotic delivery.
    Pan H; Jing H; Yang X; Pan W; Chen T
    Drug Dev Ind Pharm; 2017 May; 43(5):780-788. PubMed ID: 27278057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled release of metformin hydrochloride and repaglinide from sandwiched osmotic pump tablet.
    Qin C; He W; Zhu C; Wu M; Jin Z; Zhang Q; Wang G; Yin L
    Int J Pharm; 2014 May; 466(1-2):276-85. PubMed ID: 24607209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of controlled release osmotic pump tablet of glipizide solid dispersion.
    Patel GC; Asodaria KV; Patel HP; Shah DR
    Curr Drug Deliv; 2014; 11(6):817-27. PubMed ID: 23859357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and in vitro studies of a fixed-dose combination of a bilayer matrix tablet containing metformin HCl as sustained release and glipizide as immediate release.
    Mandal U; Pal TK
    Drug Dev Ind Pharm; 2008 Mar; 34(3):305-13. PubMed ID: 18363146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo and in vitro evaluation of three controlled release principles of 6-N-cyclohexyl-2'-O-methyladenosine.
    Royce A; Li S; Weaver M; Shah U
    J Control Release; 2004 May; 97(1):79-90. PubMed ID: 15147806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inlay osmotic pump tablets containing metformin and glipizide.
    Patel RB; Patel GN; Patel HR; Patel MM
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1244-52. PubMed ID: 21466414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of glipizide push-pull osmotic pump controlled release tablets by using expert system and artificial neural network].
    Zhang ZH; Wang Y; Wu WF; Zhao X; Sun XC; Wang HQ
    Yao Xue Xue Bao; 2012 Dec; 47(12):1687-95. PubMed ID: 23460977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and evaluation of a novel floating osmotic pump system.
    Zhang Z; Peng B; Yang X; Wang C; Sun G; Pan W
    J Pharm Pharm Sci; 2009; 12(1):129-37. PubMed ID: 19470297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and optimization of osmotically controlled release tablets of glipizide: hot melt granulation.
    Panda RR; Tiwary AK
    Ther Deliv; 2010 Dec; 1(6):763-74. PubMed ID: 22834012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended release dosage form of glipizide: development and validation of a level A in vitro-in vivo correlation.
    Ghosh A; Bhaumik UK; Bose A; Mandal U; Gowda V; Chatterjee B; Chakrabarty US; Pal TK
    Biol Pharm Bull; 2008 Oct; 31(10):1946-51. PubMed ID: 18827360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of bioadhesive glipizide spheres and compacts from spheres prepared by extruder/marumerizer technique.
    Garcia J; Ghaly ES
    Pharm Dev Technol; 2001 Aug; 6(3):407-17. PubMed ID: 11485182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
    Sankalia JM; Sankalia MG; Mashru RC
    J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
    Hu LD; Liu Y; Tang X; Zhang Q
    Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclodextrin complex osmotic tablet for glipizide delivery.
    Gan Y; Pan W; Wei M; Zhang R
    Drug Dev Ind Pharm; 2002 Sep; 28(8):1015-21. PubMed ID: 12378956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of natural and synthetic hydrophilic polymers in the formulation of metformin hydrochloride tablets with different profile release].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(3-4):167-84. PubMed ID: 23457958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled release matrix tablets of glipizide: Influence of different grades of ethocel and Co-excipient on drug release.
    Mehsud SU; Khan GM; Hussain A; Akram M; Akhlaq M; Khan KA; Shakoor A
    Pak J Pharm Sci; 2016 May; 29(3):779-87. PubMed ID: 27166548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastro-floating bilayer tablets for the sustained release of metformin and immediate release of pioglitazone: preparation and in vitro/in vivo evaluation.
    He W; Li Y; Zhang R; Wu Z; Yin L
    Int J Pharm; 2014 Dec; 476(1-2):223-31. PubMed ID: 25283698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing of the fixed-dose gastroretentive bilayer tablet for sustained release of metformin and immediate release of atorvastatin.
    Oh JH; Eun Lee J; Jeong Kim Y; Oh TO; Han S; Jeon EK; Shin K; Kim DH; Hye Park C; Lee YJ
    Drug Dev Ind Pharm; 2016; 42(2):340-9. PubMed ID: 26467296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.